- Home
- LNW vs BBIO Comparison
LNW vs BBIO Comparison
Compare LNW & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- BBIO
- Stock Information
- Founded
- LNW 1984
- BBIO 2015
- Country
- LNW United States
- BBIO United States
- Employees
- LNW N/A
- BBIO N/A
- Industry
- LNW EDP Services
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LNW Technology
- BBIO Health Care
- Exchange
- LNW Nasdaq
- BBIO Nasdaq
- Market Cap
- LNW 6.9B
- BBIO 6.7B
- IPO Year
- LNW N/A
- BBIO 2019
- Fundamental
- Price
- LNW $81.49
- BBIO $34.17
- Analyst Decision
- LNW Buy
- BBIO Strong Buy
- Analyst Count
- LNW 12
- BBIO 12
- Target Price
- LNW $109.08
- BBIO $57.09
- AVG Volume (30 Days)
- LNW 1.2M
- BBIO 3.1M
- Earning Date
- LNW 05-07-2025
- BBIO 04-29-2025
- Dividend Yield
- LNW N/A
- BBIO N/A
- EPS Growth
- LNW 56.05
- BBIO N/A
- EPS
- LNW 3.74
- BBIO N/A
- Revenue
- LNW $3,206,000,000.00
- BBIO $127,415,000.00
- Revenue This Year
- LNW $8.75
- BBIO $13.67
- Revenue Next Year
- LNW $6.40
- BBIO $118.02
- P/E Ratio
- LNW $21.82
- BBIO N/A
- Revenue Growth
- LNW 7.30
- BBIO N/A
- 52 Week Low
- LNW $75.46
- BBIO $21.62
- 52 Week High
- LNW $115.00
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- LNW 41.44
- BBIO 44.19
- Support Level
- LNW $82.51
- BBIO $33.92
- Resistance Level
- LNW $95.15
- BBIO $39.16
- Average True Range (ATR)
- LNW 3.50
- BBIO 1.50
- MACD
- LNW 0.53
- BBIO -0.24
- Stochastic Oscillator
- LNW 25.64
- BBIO 10.35
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.